1. Home
  2. MTZ vs BIO Comparison

MTZ vs BIO Comparison

Compare MTZ & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$381.13

Market Cap

24.9B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$287.98

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTZ
BIO
Founded
1929
1952
Country
United States
United States
Employees
N/A
7450
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.9B
6.9B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
MTZ
BIO
Price
$381.13
$287.98
Analyst Decision
Strong Buy
Buy
Analyst Count
18
4
Target Price
$339.47
$339.75
AVG Volume (30 Days)
967.7K
430.6K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
146.12
N/A
EPS
0.77
N/A
Revenue
$14,299,171,000.00
N/A
Revenue This Year
$20.38
$2.74
Revenue Next Year
$10.18
$3.20
P/E Ratio
$504.12
$9.72
Revenue Growth
16.22
N/A
52 Week Low
$152.43
$211.43
52 Week High
$441.43
$343.12

Technical Indicators

Market Signals
Indicator
MTZ
BIO
Relative Strength Index (RSI) 45.70 61.14
Support Level $369.04 $259.31
Resistance Level $438.66 $288.48
Average True Range (ATR) 17.14 8.98
MACD -7.47 4.66
Stochastic Oscillator 15.87 93.29

Price Performance

Historical Comparison
MTZ
BIO

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: